ALEMG — Laboratoires Euromedis SA Balance Sheet
0.000.00%
- €11.18m
- €4.02m
- €36.22m
- 42
- 64
- 47
- 48
Annual balance sheet for Laboratoires Euromedis SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | FAS | FAS | FAS | FAS | FAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 15.7 | 31.9 | 26.8 | 18.8 | 15.2 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 27.7 | 19.2 | 11.1 | 9.59 | 8.64 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 83.3 | 64.4 | 51.9 | 39.3 | 37.6 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 4.27 | 4.4 | 4.32 | 0.627 | 0.813 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 92.6 | 72.7 | 59.9 | 46.3 | 38.8 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 32.8 | 13.1 | 9.88 | 20.4 | 20.3 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 53.9 | 31.7 | 25.2 | 23.7 | 22.3 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 38.7 | 41 | 34.7 | 22.6 | 16.5 |
| Total Liabilities & Shareholders' Equity | 92.6 | 72.7 | 59.9 | 46.3 | 38.8 |
| Total Common Shares Outstanding |